Motoyasu Kato

1.8k citations
51 papers · 1.2k indexed · h-index 15

Motoyasu Kato

47 papers receiving 1.2k citations

Peers

Motoyasu Kato
Comparison fields: 5 of 83
  • Pulmonary and Respiratory Medicine 690
  • Oncology 496
  • Cancer Research 267
  • Physiology 158
  • Molecular Biology 362
Replace Nobuhiro Kanaji with:
Nobuhiro Kanaji Japan
Hisatsugu Goto Japan
Kippei Ohgaki Japan
Chan Kwon Park South Korea
Makoto Takahama Japan
Daisuke Izumi Japan
Yoshihiro Tatsumi Japan
Makoto Kawaishi Japan
Kazuhiro Koikawa Japan
Motoyasu Kato relative to Nobuhiro Kanaji Japan Nobuhiro Kanaji's profile →
Citations per field
00.5×1.7×
Nobuhiro Kanaji · 1×
Citations per year

Countries citing papers authored by Motoyasu Kato

Since Specialization
Citations

This map shows the geographic impact of Motoyasu Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motoyasu Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motoyasu Kato more than expected).

Fields of papers citing papers by Motoyasu Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motoyasu Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motoyasu Kato. The network helps show where Motoyasu Kato may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Motoyasu Kato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Motoyasu Kato Line = papers co-authored together Motoyasu Kato links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20240
3 20240
4 202117
5 202116
6 20215
7 20209
8 20201
9 201912
10 201830
11 201820
12 20174
13 20176
14 201711
15 201614
16 20141
17 201437
18 2014105
19 201111
20
Evaluation of the Relationship between a Face Anxiety Scale and the State-Trait Anxiety Inventory
19951

About Motoyasu Kato

Motoyasu Kato is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology, having authored 51 papers that have together received 1.2k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Lung Cancer Treatments and Mutations (12 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers), Cancer Cells and Metastasis (4 papers), Eosinophilic Disorders and Syndromes (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (690 citations), Oncology (496 citations) and Cancer Research (267 citations). Motoyasu Kato has collaborated with scholars based in Japan, Indonesia and China. Frequent co-authors include Kazuhisa Takahashi, Fumiyuki Takahashi, Hitoshi Miyazawa, Koichi Hagiwara, Yoshiaki Nagai, Kunihiko Kobayashi, Minoru Kanazawa, Huqun, Kiyoshi Udagawa and Tomoaki Tanaka. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026